Tarsons Products Ltd

Tarsons Products Ltd, a key player in the Healthcare Services sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a more pronounced bearish trend. Recent technical indicators, including MACD, RSI, and moving averages, signal increasing downside pressure, reflecting the stock’s underperformance relative to broader market benchmarks such as the Sensex.

Tarsons Products Ltd touched a new 52-week and all-time low of Rs.188.5 today, marking a significant decline amid ongoing challenges reflected in its financial performance and market positioning. The stock underperformed its sector and broader indices, continuing a downward trajectory that has persisted over the past year.

Shares of Tarsons Products Ltd have declined to an all-time low, closing just 0.5% above their 52-week low of ₹190.05 on 2 Feb 2026, reflecting a sustained period of underperformance relative to the broader market and sector peers.

Tarsons Products Ltd has seen its investment rating downgraded from Strong Sell to Sell as of 1 February 2026, reflecting a complex interplay of deteriorating financial performance, subdued valuation metrics, and evolving technical indicators. Despite some mild improvements in technical trends, the company’s long-term fundamentals and market returns continue to weigh heavily on investor sentiment.

Tarsons Products Ltd has exhibited a subtle shift in its technical momentum, moving from a strongly bearish stance to a mildly bearish trend, despite ongoing challenges in price performance and market sentiment. Recent technical indicators reveal a complex interplay of signals that suggest cautious investor sentiment amid a broader downtrend in the healthcare services sector.

Tarsons Products Ltd has declined to a fresh 52-week low, closing just 1.78% above its lowest price of Rs 190.05. This marks a significant milestone in the stock’s downward trajectory, reflecting persistent challenges in its financial performance and market positioning within the healthcare services sector.

Tarsons Products Ltd, a player in the healthcare services sector, has seen its investment rating downgraded from Sell to Strong Sell as of 27 Jan 2026. This revision reflects deteriorating technical indicators, weakening financial trends, and ongoing valuation concerns, signalling heightened caution for investors amid sustained underperformance against benchmarks.

Tarsons Products Ltd, a player in the Healthcare Services sector, touched a new 52-week low of Rs.190.05 today, marking a significant decline in its stock price amid ongoing challenges reflected in its financial and market performance.

Tarsons Products Ltd, a player in the Healthcare Services sector, recorded a new all-time low of Rs.190.05 today, marking a significant milestone in its ongoing decline. The stock’s performance continues to lag behind key benchmarks, reflecting persistent difficulties in maintaining growth and investor confidence.

Tarsons Products Ltd, a key player in the healthcare services sector, is currently navigating a challenging technical landscape as momentum indicators signal a shift towards bearish trends. Despite a modest day gain of 1.16%, the stock’s broader technical parameters and recent performance relative to the Sensex suggest caution for investors.

Tarsons Products Ltd, a player in the Healthcare Services sector, has reached a new all-time low of Rs.197.1, marking a significant milestone in its ongoing decline. The stock’s recent performance reflects a sustained period of underperformance relative to market benchmarks and peers, underscoring the severity of its current position.

Tarsons Products Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 20 Jan 2026, reflecting a nuanced shift in its technical outlook despite persistent financial challenges. The healthcare services company’s Mojo Score now stands at 31.0, signalling cautious investor sentiment amid ongoing operational headwinds and valuation concerns.

Tarsons Products Ltd, a healthcare services company, continues to face significant headwinds as its share price hovers near its 52-week low of ₹198.15. Despite some mildly bullish weekly technical indicators, the overall momentum remains weak, reflected in a recent downgrade to a 'Sell' rating and a 2.24% decline in the latest trading session.

Tarsons Products Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 12 August 2025, reflecting a reassessment of the stock’s outlook. However, the analysis and financial metrics presented here are based on the company’s current position as of 12 January 2026, providing investors with the latest insights into its performance and prospects.

Tarsons Products Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 12 Aug 2025, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 01 January 2026, providing investors with the latest comprehensive view of the company’s position.

Tarsons Products, a small-cap player in the healthcare services sector, has experienced a notable revision in its market evaluation metrics, reflecting a shift in analytical perspective driven by recent financial and technical developments.